Lurasidone-β-cyclodextrin complexes: Physicochemical characterization and comparison of their antidepressant, antipsychotic activities against that of self microemulsifying formulation
Authors:
- Vaishali Y. LondheVLVaishali Y. Londhe
- Aishwarya B. DeshmaneADAishwarya B. Deshmane
- Sarita R. SinghSSSarita R. Singh
- Yogesh A. KulkarniYogesh A. Kulkarni
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1157, 395-400
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Solubility enhancement studies on lurasidone hydrochloride using mixed hydrotropyInternational Journal of Pharmaceutical Investigation, 2015
- ENHANCEMENT OF SOLUBILITY OF LURASIDONE HCL USING SOLID DISPERSION TECHNIQUEInternational Journal of Research in Ayurveda and Pharmacy, 2014
- Preparation and Evaluation of Silymarin β-cyclodextrin Molecular Inclusion ComplexesJournal of Young Pharmacists, 2011
- Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor ActivityThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Effect of method of preparation on pioglitazone HCl-β-cyclodextrin inclusion complexesAsian Journal of Pharmaceutics, 2010
- Effect of preparation method on complexation of Cefdinir with β-cyclodextrinJournal of Inclusion Phenomena and Macrocyclic Chemistry, 2009
- Size of burden of schizophrenia and psychotic disordersEuropean Neuropsychopharmacology, 2005
- The PAW test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphismLife Sciences, 1988
- The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugsPsychopharmacology, 1987
- The tail suspension test: A new method for screening antidepressants in micePsychopharmacology, 1985